510(k) device
Relieva Sinus Balloon Catheter
Acclarent, Inc. · Instrument, Ent Manual Surgical (LRC, Class I) · First FDA decision Aug 31, 2005, newest Aug 18, 2006Chronic sinusitis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
6
Naming "Relieva Sinus"
MAUDE reports
0
Brand "Relieva Sinus", since 2015
PubMed studies
0
Mentioning "Relieva Sinus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Relieva Sinus Balloon Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K061903 · Decided Aug 18, 2006 · 44 days after receipt
Device type: Instrument, Ent Manual Surgical (LRC) · Otolaryngology (ENT)
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Relieva Sinus", any status and sponsor, newest update first.
Cedars-Sinai Medical CenterAcademic, hospital or other
NCT06567821 · 50 participants (planned) · Start Sep 4, 2024 · Primary completion Oct 1, 2027
Device: RELIEVA SPINPLUS® NAV Balloon Sinusplasty System · For: Chronic Maxillary Rhinosinusitis
Sites: Los Angeles, California
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Relieva Sinus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LRC
371 reports: 219 malfunction, 141 injury, 7 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Relieva Sinus"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LRC.
- XprESS Multi-Sinus Dilation SystemEntellus Medical, Inc. · 510(k) 2015
- Vent-Os Sinus Dilation familySinusys Corporation · 510(k) 2016
- Pathassist LED Light FiberEntellus Medical, Inc. · 510(k) 2014
- Pathassist Light SeekerEntellus Medical, Inc. · 510(k) 2013
- Pathassist Light FiberEntellus Medical, Inc. · 510(k) 2012
- BB 8 Sinus Dilation KitExcelent, Inc. · 510(k) 2023
- VenSure LightGuideIntersect Ent. · 510(k) 2022
- SINUSPRIME Dilation SystemStryker Ent · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.